Codexis CDXS Stock
Codexis Price Chart
Codexis CDXS Financial and Trading Overview
| Codexis stock price | 2.26 USD |
| Previous Close | 2.76 USD |
| Open | 2.73 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1800 |
| Day's Range | 2.71 - 2.91 USD |
| 52 Week Range | 2.19 - 13.03 USD |
| Volume | 782.78K USD |
| Avg. Volume | 847.91K USD |
| Market Cap | 191.62M USD |
| Beta (5Y Monthly) | 1.636619 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.14 USD |
CDXS Valuation Measures
| Enterprise Value | 123.78M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.0210526 |
| PEG Ratio (5 yr expected) | -0.16 |
| Price/Sales (ttm) | 1.6486278 |
| Price/Book (mrq) | 1.5193223 |
| Enterprise Value/Revenue | 1.065 |
| Enterprise Value/EBITDA | -3.001 |
Trading Information
Codexis Stock Price History
| Beta (5Y Monthly) | 1.636619 |
| 52-Week Change | -68.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.03 USD |
| 52 Week Low | 2.19 USD |
| 50-Day Moving Average | 3.29 USD |
| 200-Day Moving Average | 5 USD |
CDXS Share Statistics
| Avg. Volume (3 month) | 847.91K USD |
| Avg. Daily Volume (10-Days) | 1.14M USD |
| Shares Outstanding | 66.77M |
| Float | 59.99M |
| Short Ratio | 3.84 |
| % Held by Insiders | 3.00% |
| % Held by Institutions | 94.97% |
| Shares Short | 3.92M |
| Short % of Float | 6.01% |
| Short % of Shares Outstanding | 5.87% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -41.16% |
| Operating Margin (ttm) | -40.36% |
| Gross Margin | 4.25% |
| EBITDA Margin | -35.48% |
Management Effectiveness
| Return on Assets (ttm) | -12.93% |
| Return on Equity (ttm) | -33.62% |
Income Statement
| Revenue (ttm) | 116.23M USD |
| Revenue Per Share (ttm) | 1.77 USD |
| Quarterly Revenue Growth (yoy) | -63.29% |
| Gross Profit (ttm) | 20.46M USD |
| EBITDA | -41250000 USD |
| Net Income Avi to Common (ttm) | -47853000 USD |
| Diluted EPS (ttm) | -0.69 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 102.83M USD |
| Total Cash Per Share (mrq) | 1.54 USD |
| Total Debt (mrq) | 42.34M USD |
| Total Debt/Equity (mrq) | 33.6 USD |
| Current Ratio (mrq) | 3.392 |
| Book Value Per Share (mrq) | 1.889 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.26M USD |
| Levered Free Cash Flow (ttm) | 20.71M USD |
Profile of Codexis
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 200 Penobscot Drive |
| ZIP | 94063 |
| Phone | 650 421 8100 |
| Website | https://www.codexis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 248 |
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Q&A For Codexis Stock
What is a current CDXS stock price?
Codexis CDXS stock price today per share is 2.26 USD.
How to purchase Codexis stock?
You can buy CDXS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Codexis?
The stock symbol or ticker of Codexis is CDXS.
Which industry does the Codexis company belong to?
The Codexis industry is Biotechnology.
How many shares does Codexis have in circulation?
The max supply of Codexis shares is 84.3M.
What is Codexis Price to Earnings Ratio (PE Ratio)?
Codexis PE Ratio is now.
What was Codexis earnings per share over the trailing 12 months (TTM)?
Codexis EPS is -0.89 USD over the trailing 12 months.
Which sector does the Codexis company belong to?
The Codexis sector is Healthcare.
Codexis CDXS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| NASDAQ Industrial INDS | 10871.74 USD — |
+1.48
|
— — | 10674.91 USD — | 10877.89 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}